Enanta Pharmaceuticals's total assets for Q1 2026 were $329.50M, an increase of 17.37% from the previous quarter. ENTA total liabilities were $202.91M for the fiscal quarter, a -6.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.